Biotech news
Americas
Massachusetts biotech giants clash as Genzyme alleges Sarepta's Elevidys infringes on key gene therapy patents | Despite the dispute, Elevidys $200M in sales and recent FDA approvals show success. 30 July 2024
Americas
Hongene Biotech challenged ChemGenes’ patent after litigation withdrawn | Judges said all challenged claims were unpatentable. 25 July 2024
Biotech
AI has the potential to revolutionise patent examination but uneven adoption of the technology could undermine fairness in the system, says Matthew Veale of Patsnap. 25 July 2024
Americas
Scientist and patent attorney joins boutique IP firm in Philadelphia | Former in-house counsel brings expertise representing variety of life sciences clients. 25 July 2024
Americas
Commission upholds judge’s finding that Gator Bio did not infringe lab equipment patent | Sartorius sought to assert remaining patent-in-suit covering bio-layer interferometers. 18 July 2024
Americas
Proposed change will cut down ‘patent thickets’ says FTC | Biotech firms say changes will damage innovation. 11 July 2024
Europe
UK leg of global litigation over mRNA tech sees patents ruled valid and invalid | Justice Meade follows EPO in decision on Moderna’s EP 565 patent | Pfizer and German partner BioNTech on the hook for EP 949 | Opinion on Moderna’s COVID pledge also handed down. 4 July 2024
Americas
Biomodal claims New England Biolabs infringed eight patents licensed by US non-profit | Cambridge-based firm produces ‘duet platform’ encompassing genetics and epigenetics. 4 July 2024
Americas
Magistrate stand-in not authorised to answer jury questions, says eleventh circuit in precedential opinion | Florida judge left to catch flight before verdict given | Dispute between shrimp breeders concerns “unique” breeding method. 20 June 2024
Biotech
Biotech takes legal action against Tempus AI, alleging patent infringement in Tempus's liquid biopsy products | Complaint accuses Tempus of unauthorised use of Guardant's tech crucial for cancer diagnostics. 13 June 2024